Severe Traumatic Brain InjuryPost-traumatic epilepsy with myoclonic seizuresBladder and bowel incontinenceBreast cancer (Invasive Lobular Carcinoma, 2022)Diffuse Axonal InjurySarcopenia
Crestor + Magnesium — Separate by 2+ Hours
Magnesium reduces rosuvastatin absorption by 54% when taken together.
Whey Protein + Depakine — No Longer Applicable
RESOLVED: Depakine is being tapered and will be stopped completely by ~7 Apr 2026 per Prof. Hosny. Separation rule no longer needed once Depakine is stopped.
Monitor Fluid Intake — Currently 2L/day
Current fluid intake 2L/day — monitor serum osmolality (279, borderline low). Consider 1.5L/day if SIADH confirmed.
Monitor Quetiapine Levels During CBZ Taper — No Longer Applicable
RESOLVED: Quetiapine has been STOPPED per Prof. Hosny (07 Mar 2026). No longer need to monitor levels.
Weekly CBC for ANC Monitoring
ANC 0.7 = Grade 3 neutropenia. Standard threshold for stopping CBZ is ANC <1000-1500.
Separate baclofen from protein meals/whey by 1-2 hours
Baclofen is being tapered (Prof. Hosny, 07 Mar 2026) and will be stopped by ~28 Apr 2026. Continue separation until baclofen is fully stopped. Current dose: 7.5mg AM + 10mg PM.
Monitor ammonia during protein step-up
RESOLVED: Dr. Ahmed Alous (13 Mar 2026) confirmed ammonia level is acceptable — was drawn from vein (venous), not artery. Venous ammonia is expected to be higher. Plus Depakine is being tapered/stopped, further reducing ammonia risk.
Medication Taper Schedule — Prof. Hosny (07 Mar 2026)
All changes start 17 Mar 2026:
QUETIAPINE: STOPPED immediately
DEPAKINE (Valproic Acid):
• 17 Mar – 7 Apr: 250mg evening only
• After 7 Apr: STOP completely
BACLOFEN:
• 17 Mar – 31 Mar: 7.5mg morning + 10mg evening
• 31 Mar – 14 Apr: 5mg morning + 10mg evening
• 14 Apr – 28 Apr: 2.5mg morning + 10mg evening
• After 28 Apr: STOP completely
ARICEPT (Donepezil):
• 17 Mar – 31 Mar: 5mg daily
• After 31 Mar: STOP completely
ESCITALOPRAM: START 10mg daily (mood enhancement)
Follow-up: Prof. Hosny — 7 Apr 2026
Neupogen (Filgrastim) Injection — If ANC < 0.5
Per Dr. Ahmed Alous (13 Mar 2026): Give Neupogen (Filgrastim) injection subcutaneously ONLY if ANC (Absolute Neutrophil Count) drops below 0.5 x10³/μL. Current ANC: 0.8 (Feb 28, 2026). Keep injection on hand. Monitor ANC with weekly CBC.